Lb Pharmaceuticals (LBRX) Shares Outstanding (Weighted Average) (2024 - 2026)

Lb Pharmaceuticals has reported Shares Outstanding (Weighted Average) for 3 years, with the latest figure at $28.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 7771.66% year-over-year to $28.2 million; the trailing twelve-month figure through Mar 2026 stood at $28.2 million (up 7771.66% YoY), and the FY2025 full-year result was $8.0 million, up 2145.81% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $28.2 million, up from $8.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $28.2 million in Q1 2026, with the low at $358229.0 in Q4 2024.
• Average Shares Outstanding (Weighted Average) over 3 years is $7.2 million, with a median of $3.1 million recorded in 2024.
• Year-over-year, Shares Outstanding (Weighted Average) surged 1517.15% in 2025 and surged 7771.66% in 2026.
• Tracing LBRX's Shares Outstanding (Weighted Average) over 3 years: stood at $358229.0 in 2024, then soared by 2145.81% to $8.0 million in 2025, then jumped by 251.04% to $28.2 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $28.2 million (Q1 2026), $8.0 million (Q4 2025), and $5.8 million (Q3 2025), per Business Quant data.

Peer Comparison